Ron Bentsur - Mar 17, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
Mar 17, 2022
Transactions value $
$53,410
Form type
4
Date filed
3/18/2022, 08:31 AM
Previous filing
Mar 7, 2022
Next filing
Mar 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock, par value $0.00001 Purchase $53.4K +7K +0.25% $7.63 2.82M Mar 17, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock.